本文へ移動
cccskills

その他のスキル

上記に当てはまらないスキル(1.3万 件)

価格や並び順で絞り込む

Expert-level developmental biology covering embryogenesis, cell fate determination, morphogen gradients, organogenesis, stem cells, and regenerative medicine.

日本語の概要は準備中です。原文の説明を表示しています。

luokai0/ai-agent-skills-by-luo-kai142026年5月6日 更新

Expert-level quantum mechanics knowledge. Use when working with wave functions, Schrodinger equation, quantum states, operators, uncertainty principle, quantum tunneling, spin, angular momentum, perturbation theory, or quantum entanglement. Also use when the user mentions 'wave function', 'Schrodinger', 'Heisenberg', 'quantum state', 'eigenvalue', 'superposition', 'tunneling', 'spin', 'Hilbert space', 'Dirac notation', 'commutator', or 'quantum measurement'.

日本語の概要は準備中です。原文の説明を表示しています。

luokai0/ai-agent-skills-by-luo-kai142026年5月6日 更新

Expert-level electrochemistry knowledge. Use when working with electrochemical cells, electrode potentials, Nernst equation, electrolysis, batteries, fuel cells, corrosion, electroplating, or electroanalytical methods. Also use when the user mentions 'galvanic cell', 'electrolytic cell', 'electrode potential', 'Nernst equation', 'overpotential', 'Butler-Volmer', 'battery', 'fuel cell', 'corrosion', 'electroplating', 'cyclic voltammetry', or 'impedance spectroscopy'.

日本語の概要は準備中です。原文の説明を表示しています。

luokai0/ai-agent-skills-by-luo-kai142026年5月6日 更新

Expert-level genetics covering Mendelian inheritance, molecular genetics, mutations, linkage analysis, population genetics, epigenetics, and GWAS. Covers classical and modern approaches from Mendel to CRISPR.

日本語の概要は準備中です。原文の説明を表示しています。

luokai0/ai-agent-skills-by-luo-kai142026年5月6日 更新

Expert-level condensed matter physics knowledge. Use when working with crystal structure, band theory, semiconductors, superconductivity, magnetism, phase transitions, Fermi liquids, topological materials, or strongly correlated systems. Also use when the user mentions 'band gap', 'Fermi energy', 'semiconductor', 'superconductor', 'phonon', 'crystal lattice', 'Brillouin zone', 'Bloch theorem', 'Hall effect', 'magnetism', 'phase transition', or 'topological insulator'.

日本語の概要は準備中です。原文の説明を表示しています。

luokai0/ai-agent-skills-by-luo-kai142026年5月6日 更新

Resolve a verified cluster of Rembric issues from causal root to evidence-gated closure. Use after systemic triage identifies a shared root, or when the user asks to attack issues at the root, create a mechanism map, plan a deletion-first fix, or close a fixed/stale issue cluster. Use `diagnose` for a single defect whose reproduction is not yet established.

日本語の概要は準備中です。原文の説明を表示しています。

susomejias/rembric142026年10月30日 更新

Propose a new change - create it and generate all artifacts in one step

日本語の概要は準備中です。原文の説明を表示しています。

susomejias/rembric142026年10月30日 更新

Helps users discover and install agent skills when they ask questions like "how do I do X", "find a skill for X", "is there a skill that can...", or express interest in extending capabilities. This skill should be used when the user is looking for functionality that might exist as an installable skill.

日本語の概要は準備中です。原文の説明を表示しています。

susomejias/rembric142026年10月30日 更新

This skill should be used when the user asks about "plugin settings", "store plugin configuration", "user-configurable plugin", ".local.md files", "plugin state files", "read YAML frontmatter", "per-project plugin settings", or wants to make plugin behavior configurable. Documents the .claude/plugin-name.local.md pattern for storing plugin-specific configuration with YAML frontmatter and markdown content.

日本語の概要は準備中です。原文の説明を表示しています。

susomejias/rembric142026年10月30日 更新

Enter explore mode - think through ideas, investigate problems, clarify requirements

日本語の概要は準備中です。原文の説明を表示しています。

susomejias/rembric142026年10月30日 更新

Enter explore mode - a thinking partner for exploring ideas, investigating problems, and clarifying requirements. Use when the user wants to think through something before or during a change.

日本語の概要は準備中です。原文の説明を表示しています。

susomejias/rembric142026年10月30日 更新

This skill guides individualized prostate cancer screening for transgender females receiving estrogen therapy based on personal risk. Trigger phrase: transgender female receiving estrogens.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL142026年10月28日 更新

Recommends RT-CGM devices for adult patients with well-controlled type 1 diabetes who are willing and able to use the devices on a nearly daily basis. Trigger phrases include 'Controlled T1DM patient interested in CGM' and 'Consider RT-CGM for glycemic stability in well-controlled T1DM'.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL142026年10月28日 更新

Suggests short-term, intermittent real-time CGM use in adult patients with type 2 diabetes not on prandial insulin who have A1C ≥7% and are willing and able to use the device. Triggered by phrases such as “T2DM basal-only, A1C ≥7%, consider intermittent CGM” or “Short-term CGM for non-prandial T2DM with elevated A1C”.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL142026年10月28日 更新

Recommends real-time CGM with confirmatory POC-BG for insulin dosing adjustments in insulin-treated hospitalized adults at high risk of hypoglycemia when resources and training are available. Triggers include: "Should we use CGM for insulin adjustments?" or "Is CGM appropriate for this patient?

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL142026年10月28日 更新

This skill suggests continuing personal CGM with or without ADIP rather than discontinuation for inpatients already using it who are at high risk for hypoglycemia. Trigger phrases include "Should I continue or discontinue personal CGM for this inpatient who is already using it?" and "Is it appropriate to maintain personal CGM during hospitalization?"

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL142026年10月28日 更新

Suggests initiating inpatient CGM for select diabetic patients at high risk for hypoglycemia based on Table 3 criteria. Triggers include "Should I initiate CGM for this hospitalized diabetic patient at high risk for hypoglycemia?" or "Is inpatient CGM warranted for this patient?"

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL142026年10月28日 更新

This skill determines whether inpatient diabetic patients meet high-risk criteria for CGM initiation using Table 3 factors such as age ≥65 years, BMI ≤27 kg/m², type 1 diabetes, insulin regimen, and specific clinical conditions. It is triggered by clinician questions like "Should I assess this inpatient for CGM initiation based on hypoglycemia risk?" or "Is this patient a candidate for inpatient CGM?"

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL142026年10月28日 更新

Assess whether a hospitalized adult with diabetes on insulin pump therapy remains a candidate for continued inpatient pump use. Consider triggers such as the clinician asking "Is this patient appropriate to continue insulin pump in hospital?" and evaluate for impaired consciousness, inability to adjust pump settings, critical illness, DKA, or hyperosmolar hyperglycemic state.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL142026年10月28日 更新

This skill confirms whether a hospital has the necessary policies and expertise to support inpatient insulin pump therapy, including informed consent, standardized order sets, and device management guidance for imaging and surgical procedures. Triggered by questions such as "Are hospital policies and expertise in place for insulin pump use?" to ensure safe continuation of pump therapy in noncritical illness.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL142026年10月28日 更新

This skill determines whether a patient using a hybrid closed-loop insulin pump can continue this therapy upon hospital admission. It is triggered by questions such as "Can hybrid closed-loop pump be continued given hospital constraints?"

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL142026年10月28日 更新

If CGM fails or is removed, revert the insulin pump to manual mode provided basic criteria for pump use in hospital are still met. Trigger phrase: "CGM failed, should we switch pump to manual mode?

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL142026年10月28日 更新

Verify that insulin pump supplies (provided by patient or family) will be available throughout the hospitalization to support continued pump use. Triggered by questions such as "Do we have sufficient pump supplies for the hospital stay?"

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL142026年10月28日 更新

Transition insulin pump to scheduled subcutaneous basal bolus insulin when anticipated hospital length of stay exceeds 1 to 2 days and pump expertise is unavailable. Triggers include: "Patient expected to stay >2 days, should we switch pump to scheduled insulin?

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL142026年10月28日 更新